Your browser doesn't support javascript.
loading
Validation of non-muscle-invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines.
Miyake, Makito; Kitamura, Hiroshi; Nishimura, Nobutaka; Miyamoto, Tatsuki; Nakahama, Tomonori; Fujii, Tomomi; Matsumoto, Hiroaki; Matsuyama, Hideyasu; Yonemori, Masaya; Enokida, Hideki; Taoka, Rikiya; Kobayashi, Takashi; Kojima, Takahiro; Matsui, Yoshiyuki; Nishiyama, Naotaka; Nishiyama, Hiroyuki; Fujimoto, Kiyohide.
Affiliation
  • Miyake M; Department of Urology Nara Medical University Kashihara Nara Japan.
  • Kitamura H; Department of Urology, Faculty of Medicine University of Toyama Toyama Japan.
  • Nishimura N; Department of Urology Nara Medical University Kashihara Nara Japan.
  • Miyamoto T; Department of Urology Nara Medical University Kashihara Nara Japan.
  • Nakahama T; Department of Urology Nara Medical University Kashihara Nara Japan.
  • Fujii T; Department of Diagnostic Pathology Nara Medical University Kashihara Nara Japan.
  • Matsumoto H; Department of Urology, Graduate School of Medicine Yamaguchi University Ube Yamaguchi Japan.
  • Matsuyama H; Department of Urology, Graduate School of Medicine Yamaguchi University Ube Yamaguchi Japan.
  • Yonemori M; Department of Urology JA Yamaguchi Kouseiren Nagato General Hospital Nagato Japan.
  • Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences Kagoshima University Kagoshima Japan.
  • Taoka R; Department of Urology, Graduate School of Medical and Dental Sciences Kagoshima University Kagoshima Japan.
  • Kobayashi T; Department of Urology, Faculty of Medicine Kagawa University Takamatsu Kagawa Japan.
  • Kojima T; Department of Urology Kyoto University Graduate School of Medicine Kyoto Japan.
  • Matsui Y; Department of Urology Aichi Cancer Center Nagoya Aichi Japan.
  • Nishiyama N; Department of Urology National Cancer Center Hospital Tokyo Japan.
  • Nishiyama H; Department of Urology, Faculty of Medicine University of Toyama Toyama Japan.
  • Fujimoto K; Department of Urology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
BJUI Compass ; 5(2): 269-280, 2024 Mar.
Article de En | MEDLINE | ID: mdl-38371197
ABSTRACT

Objective:

The objective of this study is to validate the predictive ability of the 2021 European Association of Urology (EAU) risk model compared to that of existing risk models, including the 2019 EAU model and risk scoring tables of the European Organization for Research and Treatment of Cancer, Club Urologico Espanol de Tratamiento Oncologico, and Japanese Nishinihon Uro-oncology Extensive Collaboration Group. Patients and

methods:

This retrospective multi-institutional database study included two cohorts-3024 patients receiving intravesical bacillus Calmette-Guerin (BCG) treatment (BCG cohort) and 789 patients not receiving BCG treatment (non-BCG cohort). The Kaplan-Meier estimate and log-rank test were used to visualize and compare oncological survival outcomes after transurethral surgery among the risk groups. Harrell's concordance index (C-index) was used to evaluate the predictive ability of the models.

Results:

We observed a risk shift from the 2019 EAU risk grouping to the 2021 EAU risk grouping in a substantial number of patients. For progression, the C-index of the 2021 EAU model was significantly higher than that of the 2019 EAU model in both the BCG (0.617 vs. 0.572; P = 0.011) and non-BCG (0.718 vs. 0.560; P < 0.001) cohorts. According to the 2021 EAU model, 731 (24%) and 130 (16%) patients in the BCG and non-BCG cohorts, respectively, were considered to have a very high risk. Survival analysis showed no significant differences among the five very high-risk subgroups in both cohorts. A major limitation was potential selection bias owing to the retrospective nature of this study.

Conclusions:

The updated 2021 EAU model showed better stratification than the three existing risk models, especially for progression, in both cohorts, determining the most appropriate postoperative treatment and identifying patients requiring intensified surveillance or early cystectomy.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BJUI Compass Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BJUI Compass Année: 2024 Type de document: Article